(TBRG) TruBridge - Ratings and Ratios

TruBridge Inc. (NASDAQ:TBRG), formerly known as Computer Programs and Systems, Inc. (CPSI), is a leading provider of healthcare information technology solutions. The company serves community hospitals, clinics, and other healthcare systems across the United States and internationally. TruBridge operates through three primary business segments: Revenue Cycle Management (RCM), Electronic Health Record (EHR), and Patient Engagement. Its comprehensive suite of services includes RCM solutions, consulting, managed IT services, analytics, and business intelligence, designed to optimize operational efficiency and financial performance for healthcare providers. The company offers acute care solutions tailored for community hospitals and physician clinics, as well as patient engagement technologies that enhance patient outcomes and care provider interactions. Additionally, TruBridge provides a range of RCM services, including eligibility verification, claim scrubbing, remittance management, and contract management. The company also delivers consulting and business management services, encoder solutions, patient management tools, financial accounting systems, clinical applications, and enterprise software solutions. Its TruBridge EHR platform includes cloud-based infrastructure, ongoing system support, and software updates, while its InstantPHR and CHBase platforms facilitate data integration and patient empowerment. Headquartered in Mobile, Alabama, TruBridge was founded in 1979 and rebranded in March 2024 to reflect its expanded focus on healthcare technology solutions. For more information, visit https://www.trubridge.com.

Based on the provided data, here is a 3-month forecast for TruBridge Inc. (NASDAQ:TBRG):

From a technical perspective, TBRG is currently trading above its 20-day and 50-day simple moving averages (SMAs) at 27.14 and 23.30, respectively, but below its 200-day SMA of 15.02. This indicates short-term bullish momentum but longer-term bearish trends. The Average True Range (ATR) of 0.98 suggests moderate volatility. Expect potential resistance at the 200-day SMA level of 15.02, with support likely near the 50-day SMA of 23.30.

Fundamentally, TBRG has a market capitalization of $423.13M, with a forward P/E ratio of 19.92, indicating expectations for future earnings growth. However, the current P/E ratio of 0.00 and a return on equity (RoE) of -34.50 raise concerns about profitability. The price-to-book (P/B) ratio of 2.44 suggests the stock may be overvalued relative to its book value. The price-to-sales (P/S) ratio of 1.25 is moderate, reflecting a reasonable valuation relative to revenue.

Combining these factors, the stock may experience short-term upward pressure due to its position above key short-term SMAs, but longer-term challenges linked to profitability and valuation metrics could limit sustained growth. Investors should monitor earnings reports and industry trends for further clarity.